Survival benefit with imatinib mesylate versus interferon-alpha-based regimens in newly diagnosed chronic-phase chronic myelogenous leukemia (Q83367463)
Jump to navigation
Jump to search
scientific article published on 18 May 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Survival benefit with imatinib mesylate versus interferon-alpha-based regimens in newly diagnosed chronic-phase chronic myelogenous leukemia |
scientific article published on 18 May 2006 |
Statements
Survival benefit with imatinib mesylate versus interferon-alpha-based regimens in newly diagnosed chronic-phase chronic myelogenous leukemia (English)
Guillermo Garcia-Manero
Hagop M Kantarjian
Moshe Talpaz
Susan O'Brien
Daniel Jones
Francis Giles
Stefan Faderl
Farhad Ravandi
Mary Beth Rios
Jianqin Shan
Jorge Cortes